Chimerix (CMRX) News Today $8.54 0.00 (0.00%) As of 04/21/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CMRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Why Chimerix Inc. (CMRX) is Surging in 2025April 30, 2025 | msn.comRenaissance Technologies LLC Sells 518,941 Shares of Chimerix, Inc. (NASDAQ:CMRX)April 27, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Coverage Initiated by Analysts at StockNews.comApril 26, 2025 | marketbeat.comMarshall Wace LLP Has $7.71 Million Position in Chimerix, Inc. (NASDAQ:CMRX)April 25, 2025 | marketbeat.com391,274 Shares in Chimerix, Inc. (NASDAQ:CMRX) Acquired by Walleye Capital LLCApril 22, 2025 | marketbeat.comEAM Investors LLC Takes $786,000 Position in Chimerix, Inc. (NASDAQ:CMRX)April 19, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Sets New 52-Week High - Time to Buy?April 17, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Now Covered by StockNews.comApril 17, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Sets New 52-Week High - Should You Buy?April 10, 2025 | marketbeat.comJAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?April 9, 2025 | msn.comChimerix, Inc. (NASDAQ:CMRX) Shares Sold by ADAR1 Capital Management LLCApril 9, 2025 | marketbeat.comStockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX)April 9, 2025 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Shares Sold by Yakira Capital Management Inc.April 8, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Reaches New 52-Week High - Time to Buy?April 4, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Makes New $183,000 Investment in Chimerix, Inc. (NASDAQ:CMRX)April 3, 2025 | marketbeat.comIs Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?April 2, 2025 | msn.comChimerix, Inc. (NASDAQ:CMRX) Sees Significant Drop in Short InterestMarch 31, 2025 | marketbeat.comStockNews.com Begins Coverage on Chimerix (NASDAQ:CMRX)March 31, 2025 | marketbeat.comChimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025March 26, 2025 | msn.comRosalind Advisors Inc. Invests $10.61 Million in Chimerix, Inc. (NASDAQ:CMRX)March 23, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Releases Earnings Results, Beats Estimates By $0.01 EPSMarch 22, 2025 | marketbeat.comChimerix reports Q4 EPS (25c), consensus (28c)March 22, 2025 | markets.businessinsider.comChimerix Reports Fourth Quarter and Year End 2024 Financial ResultsMarch 21, 2025 | globenewswire.comConnor Clark & Lunn Investment Management Ltd. Acquires 84,801 Shares of Chimerix, Inc. (NASDAQ:CMRX)March 20, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Hits New 52-Week High - Should You Buy?March 18, 2025 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Holdings Reduced by Monaco Asset Management SAMMarch 15, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Earns Hold Rating from Analysts at StockNews.comMarch 15, 2025 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of ShareholdersMarch 14, 2025 | morningstar.comMChimerix (NASDAQ:CMRX) Sets New 12-Month High - Here's What HappenedMarch 13, 2025 | marketbeat.comCHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRXMarch 10, 2025 | businesswire.comChimerix (NASDAQ:CMRX) Sees Strong Trading Volume - Should You Buy?March 8, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Upgraded at Jones TradingMarch 8, 2025 | marketbeat.comCMRX Stock Surges on JAZZ Acquisition BidMarch 8, 2025 | finance.yahoo.comCMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. ...March 7, 2025 | gurufocus.comChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 7, 2025 | globenewswire.comCMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to ShareholdersMarch 7, 2025 | globenewswire.comJefferies Financial Group Reaffirms "Hold" Rating for Chimerix (NASDAQ:CMRX)March 6, 2025 | marketbeat.comPromising Small Cap Stocks To Follow Now - March 5thMarch 6, 2025 | marketbeat.comChimerix downgraded to Hold from Buy at JonesResearchMarch 6, 2025 | markets.businessinsider.comWedbush Reiterates Neutral Rating for Chimerix (NASDAQ:CMRX)March 6, 2025 | marketbeat.comChimerix's (CMRX) Neutral Rating Reaffirmed at HC WainwrightMarch 6, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Shares Gap Up - Time to Buy?March 6, 2025 | marketbeat.comChimerix downgraded to Neutral from Outperform at WedbushMarch 6, 2025 | markets.businessinsider.comChimerix (NASDAQ:CMRX) Hits New 12-Month High - What's Next?March 6, 2025 | marketbeat.comNorth Carolina drugmaker sold in $935M dealMarch 5, 2025 | bizjournals.comCMRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chimerix, Inc. Is Fair to ShareholdersMarch 5, 2025 | tmcnet.comChimerix downgraded to Neutral from Buy at H.C. WainwrightMarch 5, 2025 | markets.businessinsider.comChimerix downgraded to Hold from Buy at JefferiesMarch 5, 2025 | msn.comHC Wainwright & Co. Downgrades Chimerix (CMRX)March 5, 2025 | msn.com$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRXMarch 5, 2025 | prnewswire.com Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CMRX Media Mentions By Week CMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRX News Sentiment▼0.000.57▲Average Medical News Sentiment CMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRX Articles This Week▼03▲CMRX Articles Average Week Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MoonLake Immunotherapeutics News Today Metsera News Today Viking Therapeutics News Today MorphoSys News Today Kymera Therapeutics News Today Alvotech News Today Immunovant News Today Crinetics Pharmaceuticals News Today Catalyst Pharmaceuticals News Today HUTCHMED News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
